GCC: Market for Other Medicaments For Therapeutic Or Prophylactic Uses 2025

Market Size for Other Medicaments For Therapeutic Or Prophylactic Uses in GCC

The GCC market for other medicaments for therapeutic or prophylactic uses amounted to $X in 2022, with an increase of X% against the previous year. Overall, consumption showed a prominent expansion. As a result, consumption attained the peak level of $X. From 2021 to 2022, the growth of the market failed to regain momentum.

Production of Other Medicaments For Therapeutic Or Prophylactic Uses in GCC

In value terms, production of other medicaments for therapeutic or prophylactic uses expanded rapidly to $X in 2022 estimated in export price. Overall, production enjoyed prominent growth. The most prominent rate of growth was recorded in 2020 with an increase of X%. Over the period under review, production of hit record highs at $X in 2016; however, from 2017 to 2022, production failed to regain momentum.

Exports of Other Medicaments For Therapeutic Or Prophylactic Uses

Exports in GCC

Exports of other medicaments for therapeutic or prophylactic uses expanded to X tons in 2022, picking up by X% against the previous year's figure. Overall, exports recorded a relatively flat trend pattern. The growth pace was the most rapid in 2014 with an increase of X%. As a result, the exports reached the peak of X tons. From 2015 to 2022, the growth of the exports of remained at a somewhat lower figure.

In value terms, exports of other medicaments for therapeutic or prophylactic uses rose markedly to $X in 2022. Over the period under review, exports saw a temperate increase. The most prominent rate of growth was recorded in 2013 with an increase of X% against the previous year. The level of export peaked at $X in 2016; however, from 2017 to 2022, the exports failed to regain momentum.

Exports by Country

The United Arab Emirates represented the largest exporting country with an export of about X tons, which resulted at X% of total exports. It was distantly followed by Saudi Arabia (X tons), Oman (X tons) and Kuwait (X tons), together comprising a X% share of total exports.

The United Arab Emirates experienced a relatively flat trend pattern with regard to volume of exports of other medicaments for therapeutic or prophylactic uses. At the same time, Oman (X%) and Kuwait (X%) displayed positive paces of growth. Moreover, Oman emerged as the fastest-growing exporter exported in GCC, with a CAGR of X% from 2012-2022. By contrast, Saudi Arabia (X%) illustrated a downward trend over the same period. Oman (X p.p.) and Kuwait (X p.p.) significantly strengthened its position in terms of the total exports, while the United Arab Emirates and Saudi Arabia saw its share reduced by X% and X% from 2012 to 2022, respectively.

In value terms, the United Arab Emirates ($X) remains the largest other medicaments for therapeutic or prophylactic uses supplier in GCC, comprising X% of total exports. The second position in the ranking was held by Saudi Arabia ($X), with a X% share of total exports. It was followed by Oman, with a X% share.

From 2012 to 2022, the average annual rate of growth in terms of value in the United Arab Emirates totaled X%. The remaining exporting countries recorded the following average annual rates of exports growth: Saudi Arabia (X% per year) and Oman (X% per year).

Export Prices by Country

The export price in GCC stood at $X per ton in 2022, picking up by X% against the previous year. Export price indicated a modest increase from 2012 to 2022: its price increased at an average annual rate of X% over the last decade. The trend pattern, however, indicated some noticeable fluctuations being recorded throughout the analyzed period. Based on 2022 figures, export price for other medicaments for therapeutic or prophylactic uses increased by X% against 2019 indices. The pace of growth appeared the most rapid in 2015 when the export price increased by X% against the previous year. Over the period under review, the export prices reached the maximum in 2022 and is likely to see gradual growth in the immediate term.

There were significant differences in the average prices amongst the major exporting countries. In 2022, amid the top suppliers, the country with the highest price was Saudi Arabia ($X per ton), while Kuwait ($X per ton) was amongst the lowest.

From 2012 to 2022, the most notable rate of growth in terms of prices was attained by Kuwait (X%), while the other leaders experienced more modest paces of growth.

Imports of Other Medicaments For Therapeutic Or Prophylactic Uses

Imports in GCC

After four years of growth, purchases abroad of other medicaments for therapeutic or prophylactic uses decreased by X% to X tons in 2022. In general, imports recorded a relatively flat trend pattern. The pace of growth appeared the most rapid in 2013 when imports increased by X%. Over the period under review, imports of reached the maximum at X tons in 2014; however, from 2015 to 2022, imports failed to regain momentum.

In value terms, imports of other medicaments for therapeutic or prophylactic uses fell rapidly to $X in 2022. Overall, imports recorded a mild contraction. The most prominent rate of growth was recorded in 2021 when imports increased by X% against the previous year. As a result, imports reached the peak of $X, and then shrank significantly in the following year.

Imports by Country

In 2022, Saudi Arabia (X tons) represented the key importer of other medicaments for therapeutic or prophylactic uses, constituting X% of total imports. The United Arab Emirates (X tons) held a X% share (based on physical terms) of total imports, which put it in second place, followed by Kuwait (X%) and Oman (X%).

From 2012 to 2022, the most notable rate of growth in terms of purchases, amongst the main importing countries, was attained by Oman (with a CAGR of X%), while imports for the other leaders experienced mixed trends in the imports figures.

In value terms, Saudi Arabia ($X) constitutes the largest market for imported other medicaments for therapeutic or prophylactic uses in GCC, comprising X% of total imports. The second position in the ranking was held by the United Arab Emirates ($X), with a X% share of total imports. It was followed by Kuwait, with a X% share.

In Saudi Arabia, imports of other medicaments for therapeutic or prophylactic uses shrank by an average annual rate of X% over the period from 2012-2022. The remaining importing countries recorded the following average annual rates of imports growth: the United Arab Emirates (X% per year) and Kuwait (X% per year).

Import Prices by Country

In 2022, the import price in GCC amounted to $X per ton, falling by X% against the previous year. In general, the import price saw a relatively flat trend pattern. The most prominent rate of growth was recorded in 2021 when the import price increased by X%. As a result, import price attained the peak level of $X per ton, and then contracted sharply in the following year.

Prices varied noticeably by country of destination: amid the top importers, the country with the highest price was Saudi Arabia ($X per ton), while Oman ($X per ton) was amongst the lowest.

From 2012 to 2022, the most notable rate of growth in terms of prices was attained by Kuwait (X%), while the other leaders experienced mixed trends in the import price figures.

Source: IndexBox Platform